Effectiveness of High-intensity Laser Therapy in De Quervain Tenosynovitis
De Quervain Disease
About this trial
This is an interventional treatment trial for De Quervain Disease focused on measuring Hand grip strength, high-intensity laser therapy, De Quervain Disease
Eligibility Criteria
Inclusion Criteria:
- patients diagnosed with unilateral De Quervain tenosynovitis 18-65 years old
Exclusion Criteria:
- pain history of less than four weeks,
- upper extremity entrapment neuropathy,
- major psychiatric disease,
- upper extremity surgical treatment history,
- malignancy history,
- chronic rheumatic disease,
- cervical radiculopathy,
- cervical myelopathy,
- local corticosteroid injection prior to De Quervain tenosynovitis and receiving physical therapy.
Sites / Locations
- Private Medar Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
high-intensity laser therapy (HILT)
sham HILT
we will apply the HILT device to the most painful area of the wrist in two phases. In both phase I and phase II, the laser will be applied using continuous circular movements. The first three sessions (phase I) will be used to provide analgesic effects at an intermittent phase, applying a 75 sec, 8 W, 6 J/cm2 treatment for a total of 150 J of energy. The subsequent six sessions (phase II) will provide a biostimulatory effect at a continuous phase, applying a 30 sec, 6 W, 120 to 150 J/cm2 treatment. The HILT will be applied for a total of nine treatment sessions over a period of three consecutive weeks.
We will apply the HILT device to the most painful area of the wrist by using continuous circular movements, but the laser instrument will switched off during applications. The sham HILT will be applied for a total of nine treatment sessions over a period of three consecutive weeks.